Compare · PROG vs UNVR
PROG vs UNVR
Side-by-side comparison of Progenity Inc. (PROG) and Univar Solutions Inc. (UNVR): market cap, price performance, sector, and recent activity on the wire.
Summary
- PROG operates in Consumer Durables, while UNVR operates in Consumer Discretionary - the two are in different parts of the market.
- UNVR is the larger of the two at $4.54B, about 20.5x PROG ($221.1M).
- UNVR has more recent analyst coverage (9 ratings vs 2 for PROG).
- Company
- Progenity Inc.
- Univar Solutions Inc.
- Price
- $0.86-5.14%
- $36.15+0.50%
- Market cap
- $221.1M
- $4.54B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2015
- News (4w)
- 0
- 0
- Recent ratings
- 2
- 9
Progenity Inc.
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA1/2 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders; and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage; maternal serum screening for chromosomal disorders; and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.
Univar Solutions Inc.
Univar Solutions Inc. distributes commodity and specialty chemical products, and related services worldwide. It also provides epoxy resins, polyurethanes, titanium dioxide, fumed silica, esters, plasticizers, silicones, and specialty amines; chemicals and service to midstream pipeline and downstream refinery operators; and commodity and specialty products for meat processing, baked goods, dairy, grain mill products, processed foods, carbonated soft drinks, fruit drinks, and alcoholic beverage markets. In addition, the company offers chemical products for use at various stages of production, from sap stain prevention to pulp and paper manufacturing; ingredients for cleaners, detergents, and disinfectant products; base stocks and performance-enhancing additives for lubricants and metalworking fluids; excipients, solvents, reactants, active pharmaceutical ingredients, and intermediates to pharmaceutical ingredient producers; and chemistries and products used to sanitize, balance, and supplement municipal and industrial water. Further, it provides transportation and warehousing services, chemicals and hazardous materials handling, waste management services, inventory management, and blending and repackaging services. Univar Solutions Inc. distributes its products through warehouse and direct-to-consumer delivery channels. The company was formerly known as Univar Inc. and changed its name to Univar Solutions Inc. in September 2019. The company was founded in 1924 and is headquartered in Downers Grove, Illinois.
Latest PROG
- Progenity Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form SC 13D/A filed by Progenity Inc. (Amendment)
- Progenity Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Progenity Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp returned 42,362 units of Series X Preferred Stock to the company
- SEC Form 4: Kotzin Brian L. returned 44 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Mohanty Aditya P. returned 178 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Alter Jeffrey D. returned 65 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Neumann Clarke returned 44 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Powell Lynne returned 45 units of Series X Preferred Stock to the company, closing all direct ownership in the company
Latest UNVR
- QXO Proposes Full Slate of Independent Directors for Election at Beacon Roofing Supply's 2025 Annual Meeting
- SEC Form SC 13G/A filed by Univar Solutions Inc. (Amendment)
- SEC Form 15-12G filed by Univar Solutions Inc.
- Univar Solutions And Kalsec Strengthen Partnership In Europe With Expanded Agreement For A Wide Range Of Food Ingredient Solutions
- Univar Solutions and Kalsec® Inc. Strengthen Partnership in Europe with Expanded Agreement for a Wide Range of Food Ingredient Solutions
- SEC Form 4: Buckup Jorge C. returned $1,032,227 worth of shares to the company (28,554 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Holcomb James B returned $965,964 worth of shares to the company (26,721 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Jerding Pat returned $1,253,610 worth of shares to the company (34,678 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Mcintyre Jennifer returned $3,019,899 worth of shares to the company (83,538 units at $36.15), closing all direct ownership in the company
- SEC Form 4: Braca Joan A. returned $339,738 worth of shares to the company (9,398 units at $36.15), closing all direct ownership in the company